Pet therapy (Animal-assisted therapy) coverage policy
Customize your policy alerts
Sign up for AmeriHealth Caritas Policy CCP.1398 alerts
Get alerted when Policy CCP.1398 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage criteria for pet therapy (animal-assisted therapy) when used as a component of psychotherapy and directed by qualified health or human service providers for AmeriHealth Caritas members. It affects providers seeking coverage and prior authorization for animal-assisted therapy services.
No material clinical or coverage changes in this revision.
Coverage Criteria for Animal-Assisted (Pet) Therapy
Medically necessary criteria
Covered when ALL of the following are met
Based on Pet Partners and professional guidelines.
Pet therapy provided as a stand-alone therapy and not as a component of a psychotherapy protocol is excluded from medical necessity.
No other explicit coverage exclusions are stated in the cited portions of the policy. The document’s references and evidence summaries (including the 2025 systematic review and guideline sources) are reported but do not add additional named exclusions beyond those above.
Pet therapy is considered not medically necessary when any of the following apply: (1) treatment goals have been achieved and the member can maintain benefit independently; (2) treatment goals have not been achieved and the member is unlikely to benefit from further treatment; (3) contraindications to pet therapy are present (for example: allergic reactions, increased anxiety around the therapy pet, infection including zoonosis, or risk of harm to the animal or member); or (4) the intervention is provided as a stand‑alone therapy rather than as part of a psychotherapy protocol.
The 2025 evidence review found partial support for brief dog‑assisted interventions producing physiological effects (for example, decreases in cortisol and increases in oxytocin), but the evidence base is limited and heterogeneous, particularly with respect to measurement timing. This limited and variable evidence is noted for context but is not used by itself to determine that services are not medically necessary.
Provider Requirements, Prior Authorization, and Documentation
Prior authorization required for initial plan, modifications, and renewals
Prior authorization is required before initiation of the treatment plan and must be obtained for any subsequent modifications; renewal of the treatment plan also requires prior authorization.
No specific prior-authorization codes or formats listed
The document excerpts do not specify particular billing or procedure codes or detailed prior-authorization submission formats for pet therapy services.
Alternative: standard guideline-directed care
Standard guideline-directed care is identified as an alternative covered service to animal-assisted therapy.
No step-therapy requirements specified
No step-therapy (required sequencing of treatments) requirements are described in the provided excerpts.
Required documentation: written goal‑oriented treatment plan and supporting records
A written, goal-oriented, documented treatment plan is required that includes clearly defined benchmarks and specified time intervals for evaluating progress; documentation must also show the treatment is delivered or directed by a qualified health or human service provider and that the therapy animal is specially trained and evaluated. Infection-prevention and animal-welfare governance per professional guidance should be documented.
- Agreed-upon treatment plan with measurable benchmarks and evaluation intervals (chunk 1).
- Evidence that treatment is delivered/directed by a qualified clinician per professional guidance (chunks 6, 7).
- Documentation that the therapy animal is specially trained/evaluated and that infection-control and animal-welfare measures are in place (chunks 6, 7).
Include references and guideline sources when supporting clinical rationale
When clinical rationale is presented to support coverage or authorization, include cited references, literature searches, and relevant professional guideline sources; no specific citation format or checklist is provided in the excerpts.
- Include literature or guideline sources used to justify clinical need (chunk 19).
- References cited in the policy include systematic reviews and professional guidance (chunk 21).
Denial risks: missing authorization or stand‑alone pet therapy
Authorizations may be denied if prior authorization is not obtained for the treatment plan or for modifications; providing pet therapy as a stand-alone activity rather than as a component of a documented psychotherapy protocol is a basis for exclusion/denial.
- Failure to obtain prior authorization for the initial plan or subsequent modifications (chunk 1).
- Providing pet therapy as a stand-alone therapy and not as part of a psychotherapy protocol (chunk 2).
No other explicit authorization triggers or denial rules listed
No additional explicit authorization triggers or denial rules are specified in these excerpts beyond the prior-authorization and stand‑alone therapy provisions.
Permitted Animal-Assisted Therapy Modalities
Animal-assisted therapy (pet therapy) — treatment modality criteria
Aligned to AVMA, Pet Partners, and other standards.
Animal-assisted therapy (dog-assisted interventions and other animal modalities referenced in systematic reviews)
See referenced systematic reviews for details (Faucher 2025 and others).
Definitions and Background on Animal-Assisted Interventions
Animal‑assisted therapy (pet therapy) is a goal‑oriented, planned, structured, and documented therapeutic intervention in which a specially trained and evaluated animal is an integral part of treatment directed or managed by qualified health or human service providers. The therapy is designed with clear treatment goals, benchmarks, and time intervals for evaluating progress, and is distinct from less‑structured animal‑assisted activities that are recreational or supportive in nature.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.